| P2093 | author name string | Joseph Bryant | |
| | Ngeh J Toyang | |
| | Charah T Watson | |
| | Henry I C Lowe | |
| | Kenneth N Ayeah | |
| P2860 | cites work | Development of a second-generation antiandrogen for treatment of advanced prostate cancer | Q24605577 |
| | Modes of resistance to anti-angiogenic therapy | Q24608005 |
| | Type-2 pericytes participate in normal and tumoral angiogenesis | Q26782015 |
| | Mechanisms of plant defense against insect herbivores | Q27014168 |
| | Tumor angiogenesis: therapeutic implications | Q27860595 |
| | Apigenin: a promising molecule for cancer prevention | Q28277257 |
| | Antimicrobial activity of flavonoids | Q28284831 |
| | Aiming High--Changing the Trajectory for Cancer | Q28596067 |
| | Cancer statistics, 2016 | Q29547383 |
| | The NCI60 human tumour cell line anticancer drug screen | Q29614975 |
| | Natural products as sources of new drugs over the 30 years from 1981 to 2010 | Q29616640 |
| | Angiogenesis as a therapeutic target | Q29619525 |
| | Apoptosis: controlled demolition at the cellular level | Q29620114 |
| | NCI-60 Cell Line Screening: A Radical Departure in its Time. | Q30383428 |
| | Induction of apoptosis in prostate cancer cell lines by a flavonoid, baicalin. | Q33181350 |
| | Dietary flavonoids as proteasome inhibitors and apoptosis inducers in human leukemia cells | Q33214476 |
| | Treatment of relapsed chronic lymphocytic leukemia by 72-hour continuous infusion or 1-hour bolus infusion of flavopiridol: results from Cancer and Leukemia Group B study 19805. | Q33366608 |
| | Labeling nuclear DNA using DAPI. | Q33785538 |
| | Analysis of Food and Drug Administration-approved anticancer agents in the NCI60 panel of human tumor cell lines | Q33843555 |
| | WST-1-based cell cytotoxicity assay as a substitute for MTT-based assay for rapid detection of toxigenic Bacillus species using CHO cell line | Q39991355 |
| | Synthetic chalcones, flavanones, and flavones as antitumoral agents: biological evaluation and structure-activity relationships | Q40154788 |
| | Oxygen‐regulated expression of the Wilms’ tumor suppressorWt1involves hypoxia‐inducible factor‐1 (HIF‐1) | Q40648946 |
| | In Vitro Anticancer Activity of the Crude Extract and two Dicinnamate Isolates from the Jamaican Ball Moss (Tillandsia Recurvata L.). | Q40751768 |
| | Apigenin Induces Apoptosis through a Mitochondria/Caspase-Pathway in Human Breast Cancer MDA-MB-453 Cells | Q43138260 |
| | Executioner caspase-3, -6, and -7 perform distinct, non-redundant roles during the demolition phase of apoptosis. | Q43509147 |
| | Antiviral activities of flavonoids and organic acid from Trollius chinensis Bunge | Q43890093 |
| | Comparison of antiangiogenic activities using paclitaxel (taxol) and docetaxel (taxotere). | Q44281300 |
| | Chemical constituents from Tillandsia recurvata | Q44907475 |
| | Flavanones inhibit the clonogenicity of HCT116 cololectal cancer cells. | Q53199535 |
| | Dietary flavonoids: intake, health effects and bioavailability | Q73132209 |
| | Combinatorial antitumor effect of naringenin and curcumin elicit angioinhibitory activities in vivo | Q84239311 |
| | Estimated dietary flavonoid intake and major food sources of U.S. adults | Q34003717 |
| | Global patterns of cancer incidence and mortality rates and trends | Q34127168 |
| | Overview of Dietary Flavonoids: Nomenclature, Occurrence and Intake | Q34266446 |
| | Deoxycholyltaurine rescues human colon cancer cells from apoptosis by activating EGFR-dependent PI3K/Akt signaling | Q34315732 |
| | Dietary flavonoids and the development of type 2 diabetes and cardiovascular diseases: review of recent findings | Q34318610 |
| | Caspase functions in cell death and disease | Q34336335 |
| | Flavonoids: a review of probable mechanisms of action and potential applications | Q34376410 |
| | On the use of neuro-2a neuroblastoma cells versus intact neurons in primary culture for neurotoxicity studies | Q34470161 |
| | Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study | Q34726987 |
| | Antiangiogenic Activity of Chemopreventive Drugs | Q35108770 |
| | Flavonoids: Promising anticancer agents | Q35112798 |
| | Biochemical pharmacology of functional foods and prevention of chronic diseases of aging | Q35187803 |
| | 5-alpha-reductase type I (SRD5A1) is up-regulated in non-small cell lung cancer but does not impact proliferation, cell cycle distribution or apoptosis. | Q35721207 |
| | Flavopiridol: pleiotropic biological effects enhance its anti-cancer activity | Q35786089 |
| | Flavonoids in food and their health benefits | Q36023128 |
| | Significance of flavonoids in plant resistance and enhancement of their biosynthesis | Q36358420 |
| | Cycloartane-3,24,25-triol inhibits MRCKα kinase and demonstrates promising anti prostate cancer activity in vitro | Q36462888 |
| | First encounters--deployment of defence-related natural products by plants | Q36601347 |
| | Randomized multicenter phase II study of flavopiridol (alvocidib), cytarabine, and mitoxantrone (FLAM) versus cytarabine/daunorubicin (7+3) in newly diagnosed acute myeloid leukemia | Q36709001 |
| | Effects of dietary flavonoids on apoptotic pathways related to cancer chemoprevention | Q36744963 |
| | Antiangiogenic effects of flavonoids and chalcones. | Q37128084 |
| | Targeting the extrinsic apoptosis pathway in cancer | Q37169988 |
| | Antitumour activity of the novel flavonoid Oncamex in preclinical breast cancer models. | Q37174733 |
| | A plant flavonoid fisetin induces apoptosis in colon cancer cells by inhibition of COX2 and Wnt/EGFR/NF-kappaB-signaling pathways | Q37292714 |
| | Impact of natural products on developing new anti-cancer agents | Q37473373 |
| | Flavonoids: chemical properties and analytical methodologies of identification and quantitation in foods and plants | Q37851445 |
| | Natural products from resurrection plants: potential for medical applications | Q38200394 |
| | Flavonoids and immune function in human: a systematic review. | Q38219164 |
| | Natural flavonoids as potential herbal medication for the treatment of diabetes mellitus and its complications | Q38446446 |
| | Prevention and treatment of cancers by immune modulating nutrients. | Q38718929 |
| | In vitro and in vivo anti-cancer effects of tillandsia recurvata (ball moss) from Jamaica | Q39021428 |
| | Naringenin (citrus flavonone) induces growth inhibition, cell cycle arrest and apoptosis in human hepatocellular carcinoma cells | Q39153997 |
| | Kinase inhibition by the Jamaican ball moss, Tillandsia recurvata L. | Q39260695 |
| | In vitro anti-prostate cancer and ex vivo antiangiogenic activity of Vernonia guineensis Benth. (Asteraceae) tuber extracts | Q39371375 |
| P921 | main subject | Tillandsia recurvata | Q2709996 |
| P304 | page(s) | 38 | |
| P577 | publication date | 2017-03-07 | |
| P1433 | published in | Cancer Cell International | Q1829859 |
| P1476 | title | HLBT-100: a highly potent anti-cancer flavanone from Tillandsia recurvata (L.) L | |
| P478 | volume | 17 | |